SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: NTTG who wrote (11176)4/24/2012 1:54:45 PM
From: TheMaster  Read Replies (1) | Respond to of 13111
 
lets discuss on your boat. Am I the only one who's invitation to meet you will not accept?



To: NTTG who wrote (11176)4/24/2012 3:39:57 PM
From: Howard Williams1 Recommendation  Read Replies (1) | Respond to of 13111
 
NTTG, why do you say there is little room for iterative discussion in the SPA process. Your own link describes it as a potentially iterative process.

"FDA can reply by simply stating that they do not agree and provide their reasons. They do not have to provide an acceptable alternative and can put the onus straight back on the company."

Putting the onus back on the company is a far cry from a flat out "no" IMO.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News